These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


205 related items for PubMed ID: 7027408

  • 21. Anticoagulants, aspirin and dipyridamole in the secondary prevention of cerebral ischaemia: which is the best for which patient?
    Halkes PH, Algra A.
    Cerebrovasc Dis; 2007; 24 Suppl 1():107-11. PubMed ID: 17971645
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. A double-blind controlled trial of low dose acetylsalicylic acid and dipyridamole in the treatment of Raynaud's phenomenon.
    van der Meer J, Wouda AA, Kallenberg CG, Wesseling H.
    Vasa Suppl; 1987; 18():71-5. PubMed ID: 3299819
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Antiaggregant therapy in cerebrovascular insufficiency in the aged].
    Fabris F, Pernigotti L.
    Clin Ter; 1979 Jan 15; 88(1):21-31. PubMed ID: 35301
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [ASS and dipyridamole combination. A decisive contribution to secondary prevention after stroke].
    Haberl R.
    MMW Fortschr Med; 2003 May 26; 145 Suppl 2():98. PubMed ID: 14579496
    [No Abstract] [Full Text] [Related]

  • 32. [Prevention of recurrences of cerebral ischemic vascular accidents by platelet antiaggregants. Results of a 3-year controlled therapeutic trial].
    Guiraud-Chaumeil B, Rascol A, David J, Boneu B, Clanet M, Bierme R.
    Rev Neurol (Paris); 1982 May 26; 138(5):367-85. PubMed ID: 6815756
    [No Abstract] [Full Text] [Related]

  • 33. For your stroke-prone patients: a guide to drug treatment.
    Yatsu FM.
    Geriatrics; 1980 Feb 26; 35(2):34-47. PubMed ID: 7356588
    [No Abstract] [Full Text] [Related]

  • 34. Summary of design features: clinical trials of platelet-active drugs in cerebrovascular disease.
    Friedman LM.
    Circulation; 1980 Dec 26; 62(6 Pt 2):V88-9. PubMed ID: 7002355
    [Abstract] [Full Text] [Related]

  • 35. Secondary stroke prevention with antiplatelet drugs: have we reached the ceiling?
    Diener HC.
    Int J Stroke; 2006 Feb 26; 1(1):4-8. PubMed ID: 18706062
    [Abstract] [Full Text] [Related]

  • 36. [Inhibition of platelet function in pediatric medicine (author's transl)].
    Schmidt B.
    Klin Padiatr; 1982 Mar 26; 194(2):91-3. PubMed ID: 7098376
    [Abstract] [Full Text] [Related]

  • 37. Aspirin and dipyridamole for the secondary prevention of stroke.
    Zielinski R, French L.
    J Fam Pract; 1999 Feb 26; 48(2):92. PubMed ID: 10037534
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Clinical inquiries. What is the best management for patients who have a TIA while on aspirin therapy?
    Ahmed N, Coffey JB, Oh R.
    J Fam Pract; 2006 Jul 26; 55(7):627-8. PubMed ID: 16822451
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.